Other Viruses Citation List: October 26 - November 8, 2012
Hepatitis B Virus
1. Hepatoprotective and Antiviral Properties of Isochlorogenic Acid A from Laggera alata against Hepatitis B Virus Infection. Hao, B.J., Y.H. Wu, J.G. Wang, S.Q. Hu, D.J. Keil, H.J. Hu, J.D. Lou, and Y. Zhao. Journal of Ethnopharmacology, 2012. 144(1): p. 190-194; PMID[22982394].
[PubMed] OV_1026-110812.
Hepatitis C Virus
2. Hepatitis C Virus Non-structural 5B Protein Interacts with Cyclin A2 and Regulates Viral Propagation. Pham, L.V., H.T. Ngo, Y.S. Lim, and S.B. Hwang. Journal of Hepatology, 2012. 57(5): p. 960-966; PMID[22796893].
[PubMed] OV_1026-110812.
3. Inhibition of Norovirus Replication by the Nucleoside Analogue 2'-C-Methylcytidine. Rocha-Pereira, J., D. Jochmans, K. Dallmeier, P. Leyssen, R. Cunha, I. Costa, M.S. Nascimento, and J. Neyts. Biochemical and Biophysical Research Communications, 2012. 427(4): p. 796-800; PMID[23063849].
[PubMed] OV_1026-110812.
Human Cytomegalovirus
4. Human Cytomegalovirus Inhibitor AL18 Also Possesses Activity against Influenza A and B Viruses. Muratore, G., B. Mercorelli, L. Goracci, G. Cruciani, P. Digard, G. Palu, and A. Loregian. Antimicrobial Agents and Chemotherapy, 2012. 56(11): p. 6009-6013; PMID[22908168].
[PubMed] OV_1026-110812.
5. Ganciclovir for Cytomegalovirus Retinitis. Sandler, S.F. and J.B. Rosenberg. Ophthalmology, 2012. 119(11): p. 2418-2419; PMID[23122474].
[PubMed] OV_1026-110812.
Citations from the ISI Web of Knowledge Listings for O.V.
6. Preclinical Characterization of JTK-853, a Novel Nonnucleoside Inhibitor of the Hepatitis C Virus RNA-dependent RNA Polymerase. Ando, I., T. Adachi, N. Ogura, Y. Toyonaga, K. Sugimoto, H. Abe, M. Kamada, and T. Noguchi. Antimicrobial Agents and Chemotherapy, 2012. 56(8): p. 4250-4256; ISI[000306826300028].
[WOS]. OV_1026-110812.
7. Synthesis of Novel Mannoside Glycolipid Conjugates for Inhibition of HIV-1 Trans-infection. Dehuyser, L., E. Schaeffer, O. Chaloin, C.G. Mueller, R. Baati, and A. Wagner. Bioconjugate Chemistry, 2012. 23(9): p. 1731-1739; ISI[000308833600004].
[WOS]. OV_1026-110812.
8. Anti-Hepatitis C Virus Activity and Toxicity of Type III Phosphatidylinositol-4-kinase Beta Inhibitors. LaMarche, M.J., J. Borawski, A. Bose, C. Capacci-Daniel, R. Colvin, M. Dennehy, J. Ding, M. Dobler, J. Drumm, L.A. Gaither, J. Gao, X. Jiang, K. Lin, U. McKeever, X. Puyang, P. Raman, S. Thohan, R. Tommasi, K. Wagner, X. Xiong, T. Zabawa, S. Zhu, and B. Wiedmann. Antimicrobial Agents and Chemotherapy, 2012. 56(10): p. 5149-5156; ISI[000308807900021].
[WOS]. OV_1026-110812.
9. Silibinin Inhibits HIV-1 Infection by Reducing Cellular Activation and Proliferation. McClure, J., E.S. Lovelace, S. Elahi, N.J. Maurice, J. Wagoner, J. Dragavon, J.E. Mittler, Z. Kraft, L. Stamatatos, H. Horton, S.C. De Rosa, R.W. Coombs, and S.J. Polyak. Plos One, 2012. 7(7); ISI[000306806600130].
[WOS]. OV_1026-110812.
10. Biosynthesis of anti-HCV Compounds Using Thermophilic Microorganisms. Rivero, C.W., E.C. De Benedetti, J.E. Sambeth, M.E. Lozano, and J.A. Trelles. Bioorganic & Medicinal Chemistry Letters, 2012. 22(19): p. 6059-6062; ISI[000309105200004].
[WOS]. OV_1026-110812.
11. Hepatitis C RNA Clearance after Treatment with Ezetimibe. Soza, A. Liver International, 2012. 32(8): p. 1323-1324; ISI[000307722000019].
[WOS]. OV_1026-110812.